The Medicines Company Surges Amid Credit Suisse Upgrade By: Benzinga via Benzinga November 20, 2014 at 10:16 AM EST Credit Suisse upgraded The Medicines Company (NASDAQ: MDCO) Thursday from Neutral to Outperform and raised its price target from $27 ... Read More >> Related Stocks: Medicines Company